Latest News for: tregs

Edit

Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg Expansion in Healthy Volunteer Study (Fund + NV)

Public Technologies 01 Oct 2026
EGL-003 produced selective, dose-dependent Treg expansion without amplification of conventional CD4, CD8 or NK cell populations ... CLA-negative Tregs, by contrast, remained elevated in circulation.
Edit

Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg ...

Nasdaq Globe Newswire 30 Sep 2026
An IL-2 Mutein Inducing Potent and Selective Amplification of Treg with Preferential Activation of Effector/Memory Skin Homing Tregs,” Abstract / ePoster AS-3660 / P1719).
Edit

Global Brain has made an additional investment in RegCell, Inc., a biotechnology company developing an epigenetic regulatory T-cell (Treg) reprogramming platform for autoimmune diseases (Global Brain Corp)

Public Technologies 29 Sep 2026
(RegCell), a biotechnology company developing an epigenetic regulatory T-cell (Treg) reprogramming platform for autoimmune diseases, through its Global Brain Flagship Fund IX and 321FORCE Global Innovation Fund L.P.
Edit

Lupus Foundation of America Funds Innovative Research Studying CAR-Treg Therapy for Children with Lupus

PR Newswire 14 Jul 2026
Wobma will be studying CAR-Treg's capacity to restore immune balance and subsequent disease remission in children with lupus ... Wobma will be studying how regulatory T cells (Tregs) - immune cells that ...
  • 1
×